Information  X 
Enter a valid email address

Reckitt Benckiser Gp (RKT)

  Print          Annual reports

Thursday 09 September, 2021

Reckitt Benckiser Gp

Closing sale of IFCN China business to Primavera

RNS Number : 2682L
Reckitt Benckiser Group PLC
09 September 2021
 

Reckitt announces closing of sale of IFCN business in China to Primavera  

 

9 September 2021 - Slough, UK - Reckitt Benckiser Group plc ("Reckitt") is pleased to announce that it has today completed the sale, announced on 5 June 2021, of its Infant Formula and Child Nutrition ("IFCN") business in China* to Primavera Capital Group ("Primavera"). 

 

All conditions to completion of the transaction have been satisfied. 

 

Commenting on the sale, Reckitt CEO Laxman Narasimhan said:  

 

"Coming just six-and-a-half months after announcing the strategic review in February, the closing today represents a major step forward in our strategy to rejuvenate sustainable growth. Our Nutrition business is now stronger and more concentrated in attractive markets such as North America, Latin America and ASEAN. We remain fully focused on executing our strategy, investing for growth and achieving our medium-term targets.

 

"To those Reckitt team members who will start a new chapter today, I want to thank you for all of your contributions to Reckitt and wish you well."  

* Mainland China, Taiwan, Hong Kong

 

 

For further information, please contact: 


Reckitt  


Simon Whittington  

Deputy Head of Investor Relations 

 

+44 (0)7408 812062  

Patty O'Hayer  

Director, External Relations and Government Affairs 

 

+44 (0)7825 755688  

Finsbury  

Faeth Birch  

 

+44 (0)7768 943171  

 

 

 

About Reckitt  

 

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege. 

 

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more. 

 

Every day, more than 20 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always. 

 

We are a diverse global team of more than 43,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society.  Find out more, or get in touch with us at  www.reckitt.com

 

*Reckitt is the trading name of the Reckitt Benckiser group of companies 

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISUPUGPBUPGURB

a d v e r t i s e m e n t